BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 26738671)

  • 1. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
    Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
    Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
    Hale SL; Mehra A; Leeka J; Kloner RA
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H421-5. PubMed ID: 17993599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: how fast and accurate can myocardial infarct size and no-reflow be predicted?
    Uitterdijk A; Sneep S; van Duin RW; Krabbendam-Peters I; Gorsse-Bakker C; Duncker DJ; van der Giessen WJ; van Beusekom HM
    Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1104-10. PubMed ID: 23873799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
    Dai W; Hale S; Kloner RA
    Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size.
    Hale SL; Herring MJ; Kloner RA
    J Am Heart Assoc; 2013 Jan; 2(1):e004234. PubMed ID: 23525431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effects of intracoronary administration of 4-chlorodiazepam in small and large animal models of ischemia-reperfusion.
    Tsamatsoulis M; Kapelios CJ; Katsaros L; Vakrou S; Sousonis V; Sventzouri S; Michelinakis N; Perrea DN; Anastasiou-Nana M; Malliaras K
    Int J Cardiol; 2016 Dec; 224():90-95. PubMed ID: 27643472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
    Monassier JP
    Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion.
    Han B; Zhang X; Zhang Q; Zhao G; Wei J; Ma S; Zhu W; Wei M
    Arch Cardiovasc Dis; 2011 May; 104(5):313-24. PubMed ID: 21693368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
    Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA
    Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model.
    Dai W; Amoedo ND; Perry J; Le Grand B; Boucard A; Carreno J; Zhao L; Brown DA; Rossignol R; Kloner RA
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):217-227. PubMed ID: 33555510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beneficial effects of adenosine on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; Jing ZC; Wu YJ; You SJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):453-8. PubMed ID: 15932708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary Infusion of Thioflavin-S to Study Microvascular Obstruction in a Model of Myocardial Infarction.
    Hervas A; de Dios E; Forteza MJ; Miñana G; Nuñez J; Ruiz-Sauri A; Bonanad C; Perez-Sole N; Chorro FJ; Bodi V
    Rev Esp Cardiol (Engl Ed); 2015 Nov; 68(11):928-34. PubMed ID: 26253860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model.
    Stavrakis S; Terrovitis J; Tsolakis E; Drakos S; Dalianis A; Bonios M; Koudoumas D; Malliaras K; Nanas J
    J Cardiovasc Transl Res; 2011 Feb; 4(1):99-105. PubMed ID: 21153063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of Both Early Reperfusion and Therapeutic Hypothermia in Limiting Myocardial Infarct Size Post-Cardiac Arrest in a Porcine Model.
    Kern KB; Hanna JM; Young HN; Ellingson CJ; White JJ; Heller B; Illindala U; Hsu CH; Zuercher M
    JACC Cardiovasc Interv; 2016 Dec; 9(23):2403-2412. PubMed ID: 27838268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection.
    Osipov RM; Robich MP; Feng J; Liu Y; Clements RT; Glazer HP; Sodha NR; Szabo C; Bianchi C; Sellke FW
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):287-97. PubMed ID: 19620880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.